Corrected: FDA pushes back review of GlaxoSmithKline treatment for restless leg syndrome
Get the latest news alerts: Follow LTW at Twitter.
Local Tech Wire
Editor's note: XenoPort issued a correction to a press release issued last Friday about the FDA delay in review of a proposed drug. Rather than a treatment for shingles, XenoPort said the drug involved is for restless leg syndrome.
"The NDA currently under review by the FDA is for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS). The original PDUFA date for this NDA review was November 9, 2009," XenoPort said.
RESEARCH TRIANGLE PARK, N.C. – The U.S. Food and Drug Administration has pushed back its delay of a proposed treatment for restless leg syndrome that is being developed by GlaxoSmithKline (NYSE: GSK) and California-based XenoPort.
The companies announced the FDA’s decision after markets closed on Friday.
The FDA had been expected to announce a decision on the new drug application filed by GSK and XenoPort on Nov. 9. Instead, the FDA requested additional data and pushed back the review date to Feb. 9, 2010.
GSK maintains its U.S. headquarters in RTP and employs some 4,000 people in the area.
Copyright 2010 Local Tech Wire. All rights reserved.
Featured
Hot Off The Wire
- Hot Off the Wire – Google slashes Nexus One termination fee; MySpace Music tunes up audio ads; Barry Diller’s IAC beats Street
- Hot Off the Wire – Man convicted in first economic espionage case; iPhone market share grows; Electronic Arts shares falter after revenue forecast; Phone company wants to charge Google
- FairPoint looks to cut debt by two thirds with bankruptcy plan
E-mail Preferences
The Skinny
- Gears of War 3 coming? EA discloses Epic game for 2011
- Nagoya University bridges East, West with Nu Tech event
- E-mail services provider iContact investigating a hack attack
- Cyberespionage? Cyberslueths disclose Lenovo’s 2010 ‘roadmap’
- Tech recovery is at hand, analysts tells N.C. IT execs
- Believe it - Triangle region lands record $1.9B in business projects
- Epic Games’ heroes take their guns to a new world – ‘Lost Planet 2’
- IPO rewards: Motricity CEO gets a $75,000 raise in new contract
- IT recession over? Spending will rebound, analysis firm says
- Google vs. the Dragon – War over words could ignite into flames

